Recent developments to share with you

CDMO One-Stop Services for the Full Drug R&D and Manufacturing Lifecycle – Kangchuanji's Successful Participation in the Nanjing QianTuHui Conference

2024-07-21

On July 18-19, the 88th Pharmaceutical QianTuHui Conference & National New Drug R&D and Investment M&A Summit was held at Nanjing Fengda International Hotel. Kangchuanji was invited to attend and set up a booth (Booth No. B02).

During the conference, Kangchuanji not only showcased our R&D strengths and product features but also provided a platform for meaningful exchanges. Our business team actively engaged with every visitor, listened to their needs, shared insights, and explored potential collaborations.

Although the conference has successfully concluded, our journey continues. Kangchuanji will keep a close eye on market demands, maintain close contact with industry clients, and provide better products and services to all our partners. We will turn the valuable information and inspiration gained at the conference into concrete actions, driving Kangchuanji's continued growth and contributing to the advancement of the industry.

We sincerely thank all the friends who visited our booth. Your support and trust are what drive us forward. Kangchuanji is always committed to providing you with better products and services, and we look forward to working with you!

Keywords：

Quality is the lifeline of an enterprise – its core and soul.

Good News! Kangchuanji Helps Partner Achieve China's First Generic Drug Consistency Evaluation for Co-Trimoxazole Injection

Related information

Bountiful Results | January–July 2026: Kangchuanji Pharmaceutical, in collaboration with multiple pharmaceutical companies, secured approval or passed the evaluation for 15 product specifications.

From January to July 2026, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd., leveraging its deep-rooted pharmaceutical R&D expertise and mature end-to-end CDMO capabilities, has provided robust support for the innovative R&D and commercialization of its partner companies, achieving further regulatory‑review milestones in collaboration with multiple partners. According to the NMPA’s public announcement of drug approval documents, a total of 12 drug products (covering 15 specifications) have been successfully approved or passed consistency evaluation, demonstrating significant results in translating innovative research into tangible outcomes.

2026-08-04

CDE Announcement: Updated Guidelines for Pediatric Medicines! “Technical Guidance on the Application of Physiologically Based Pharmacokinetic Models in Drug Development for Pediatric Populations (Draft for Public Comment)”

On August 17, the CDE released a draft of the “Technical Guidance for the Application of Physiologically Based Pharmacokinetic Models in Pediatric Drug Development” for public comment.

2024-10-27

Good news keeps pouring in: Jiuzhou Pharmaceutical’s Kangchuanji Pharmaceutical has helped its partner obtain marketing approval for Rosuvastatin–Ezetimibe Tablets (I).

2026-07-03

Please contact us for more detailed information.

Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!

Nanjing Kangchuanji Pharmatech Co., Ltd.

Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

南京康川济医药科技有限公司

Recent developments to share with you

CDMO One-Stop Services for the Full Drug R&D and Manufacturing Lifecycle – Kangchuanji's Successful Participation in the Nanjing QianTuHui Conference

COOKIES

COOKIES